Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Raf-1 Keeps Developing Blood Vessel Cells Grouped Together

By LabMedica International staff writers
Posted on 30 Jan 2012
The elegant interaction between two molecular signaling pathways is critical to the process by which new blood vessels are formed (sprouting angiogenesis), and drugs that interfere with this interaction are being evaluated as possible chemotherapeutic agents.

Investigators at the University of Vienna (Austria) and the Medical University of Vienna (Austria) used video microscopy of developing blood vessels in vitro to study the interaction between the enzymes Raf-1(rapidly accelerated fibrosarcoma protein) and Rok-alpha.

Raf-1 is a MAP (mitogen-activated protein) kinase kinase kinase (MAP3K), which functions downstream of the Ras family of membrane associated GTPases to which it binds directly. More...
Once activated, the cellular RAF1protein can phosphorylate to activate the dual specificity protein kinases MEK1 and MEK2, which in turn phosphorylate to activate the serine/threonine specific protein kinases, ERK1 and ERK2. Activated ERKs are effectors of cell physiology and play an important role in the control of gene expression involved in the cell division cycle, apoptosis, cell differentiation, and cell migration.

Rok-alpha is a serine/threonine kinase that regulates cytokinesis, smooth muscle contraction, the formation of actin stress fibers and focal adhesions, and the activation of the c-fos serum response element.

New findings published in the December 29, 2011, online edition of the journal Developmental Cell revealed that that Raf-1 was an essential component of the angiogenesis regulatory network, and that its removal impaired endothelial cell cohesion, sprouting, and tumor-induced angiogenesis. Mechanistically, Raf-1 was recruited to VE-cadherin complexes by a mechanism involving the small G protein Rap1 and was required to bring the Rho effector Rok-alpha to emerging adherens junctions (sites of connection between cells). This Raf-1-mediated fine-tuning of Rok-alpha signaling allowed the activation of junctional myosin and the timely maturation of adherens junctions essential for maintaining cell cohesion during sprouting angiogenesis.

“The real breakthrough came when we were able to use video microscopy on the developing vessels in vitro,” explained first author Reiner Wimmer, a researcher at the University of Vienna. “We realized that the cells without Raf-1 were actively migrating, but only as single cells. They could not migrate in a group.”

Related Links:

University of Vienna
Medical University of Vienna


Gold Member
Fibrinolysis Assay
HemosIL Fibrinolysis Assay Panel
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Silver Member
PCR Plates
Diamond Shell PCR Plates
Sperm Quality Analyis Kit
QwikCheck Beads Precision and Linearity Kit
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.